Paper35480205
Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition.
Dos Santos WH and 5 others. RSC Adv, 2021. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition. Papers, record 35480205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35480205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25254058 | Caffeic Acid phenethyl ester: consequences of its hydrophobicity in the oxidative functions and cytokine release by leukocytes. | Evid Based Complement Alternat Med | 2014 | https://conductscience.org/library/papers/25254058 | PubMed |
| 2 | 28647857 | ROS-modulated therapeutic approaches in cancer treatment. | J Cancer Res Clin Oncol | 2017 | https://conductscience.org/library/papers/28647857 | PubMed |
| 3 | 29876988 | Reactive oxygen species-mediated phosphorylation of p38 signaling is critically involved in apoptotic effect of Tanshinone I in colon cancer cells. | Phytother Res | 2018 | https://conductscience.org/library/papers/29876988 | PubMed |
| 4 | 27638330 | The impact of thalidomide use in birth defects in Brazil. | Eur J Med Genet | 2017 | https://conductscience.org/library/papers/27638330 | PubMed |
| 5 | 30577600 | Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30577600 | PubMed |
| 6 | 27099438 | Gallic acid induced apoptotic events in HCT-15 colon cancer cells. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27099438 | PubMed |
| 7 | 28131839 | Myeloperoxidase amplified high glucose-induced endothelial dysfunction in vasculature: Role of NADPH oxidase and hypochlorous acid. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28131839 | PubMed |
| 8 | 26056983 | Albumin-induced circular dichroism in Congo red: Applications for studies of amyloid-like fibril aggregates and binding sites. | Spectrochim Acta A Mol Biomol Spectrosc | 2015 | https://conductscience.org/library/papers/26056983 | PubMed |
| 9 | 30084091 | The defense and signaling role of NADPH oxidases in eukaryotic cells : Review. | Wien Med Wochenschr | 2018 | https://conductscience.org/library/papers/30084091 | PubMed |
| 10 | 31670229 | Thalidomide prevents antibody-mediated immune thrombocytopenia in mice. | Thromb Res | 2019 | https://conductscience.org/library/papers/31670229 | PubMed |
| 11 | 30005203 | Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. | Bioorg Chem | 2018 | https://conductscience.org/library/papers/30005203 | PubMed |
| 12 | 35514705 | Methyl divanillate: redox properties and binding affinity with albumin of an antioxidant and potential NADPH oxidase inhibitor. | RSC Adv | 2019 | https://conductscience.org/library/papers/35514705 | PubMed |
| 13 | 18086956 | Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. | Hypertension | 2008 | https://conductscience.org/library/papers/18086956 | PubMed |
| 14 | 8018341 | Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. | Am J Respir Cell Mol Biol | 1994 | https://conductscience.org/library/papers/8018341 | PubMed |
| 15 | 25658730 | [NADPH oxidases, Nox: new isoenzymes family]. | Med Sci (Paris) | 2015 | https://conductscience.org/library/papers/25658730 | PubMed |
| 16 | 27470354 | The inhibitory effects of carnosic acid on cervical cancer cells growth by promoting apoptosis via ROS-regulated signaling pathway. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27470354 | PubMed |
| 17 | 28640317 | Octyl gallate, a food additive with potential beneficial properties to treat Helicobacter pylori infection. | Food Funct | 2017 | https://conductscience.org/library/papers/28640317 | PubMed |
| 18 | 30632295 | The roles of NADPH oxidase in modulating neutrophil effector responses. | Mol Oral Microbiol | 2019 | https://conductscience.org/library/papers/30632295 | PubMed |
| 19 | 19309261 | Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. | Antioxid Redox Signal | 2009 | https://conductscience.org/library/papers/19309261 | PubMed |
| 20 | 25340774 | Improvement of pro-oxidant capacity of protocatechuic acid by esterification. | PLoS One | 2014 | https://conductscience.org/library/papers/25340774 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42719255 | Multiscale mechanistic modeling for the rational design of novel dual-target candidates against acetylcholinesterase and NADPH oxidase: an advanced computational study. | Front Chem | 2026 | https://conductscience.org/library/papers/42719255 | PubMed |
| 41186847 | Pre-treatment with caffeic acid-phthalimide prevents UVB-induced oxidative stress and cytotoxicity. | Photochem Photobiol Sci | 2025 | https://conductscience.org/library/papers/41186847 | PubMed |
| 37894747 | A Comparative Study of the Inhibitory Effect of Some Flavonoids and a Conjugate of Taxifolin with Glyoxylic Acid on the Oxidative Burst of Neutrophils. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894747 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CYBA | 1535 | PubTator's text mining | https://conductscience.org/library/genes/1535 | NCBI Gene |
| CYBB | 1536 | PubTator's text mining | https://conductscience.org/library/genes/1536 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| MPO | 4353 | PubTator's text mining | https://conductscience.org/library/genes/4353 | NCBI Gene |
| NCF1 | 653361 | PubTator's text mining | https://conductscience.org/library/genes/653361 | NCBI Gene |
| NCF2 | 4688 | PubTator's text mining | https://conductscience.org/library/genes/4688 | NCBI Gene |
| NOX5 | 79400 | PubTator's text mining | https://conductscience.org/library/genes/79400 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35480205
GET https://conductscience.org/api/papers/v1/35480205/references?page=2